Get started
Author

Chuang Qi

Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer
2019 · Jianchun Duan, Longgang Cui, et al. · JAMA Oncology · 349
PDF
Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial
2022 · Yongxiang Xia, Weiwei Tang, et al. · Journal for ImmunoTherapy of Cancer · 227
PDF
Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC
2020 · Kai Zhang, Xiaohua Hong, et al. · Clinical Cancer Research · 120
Allele Frequency–Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors
2019 · Zhijie Wang, Jianchun Duan, et al. · Journal of Thoracic Oncology · 85
PDF
PD-1 blockade plus chemoradiotherapy as preoperative therapy for patients with BRPC/LAPC: A biomolecular exploratory, phase II trial
2023 · Juan Du, Changchang Lu, et al. · Cell Reports Medicine · 41
Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer
2023 · Tian-mei Zeng, Guang Yang, et al. · Nature Communications · 37
PDF
EGFR L747P mutation in one lung adenocarcinoma patient responded to afatinib treatment: a case report
2018 · Tong Zhou, Xiaoyue Zhou, et al. · Journal of Thoracic Disease · 21
PDF
PAPPA2 mutation as a novel indicator stratifying beneficiaries of immune checkpoint inhibitors in skin cutaneous melanoma and non‐small cell lung cancer
2022 · Yiting Dong, Lele Zhao, et al. · Cell Proliferation · 16
PDF
The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer
2022 · Yong Wang, Ningning Luo, et al. · Journal of Cancer Research and Clinical Oncology · 16
Molecular and clinicopathological characteristics of ERBB2 gene fusions in 32,131 Chinese patients with solid tumors
2022 · Yin Guan, Yutong Wang, et al. · Frontiers in Oncology · 13
Molecular and Clinicopathological Characteristics of Lung Cancer Concomitant Chronic Obstructive Pulmonary Disease (COPD)
2022 · Hongxia Ma, Qian Zhang, et al. · International Journal of COPD · 13
PDF
NOTCH4 mutation as predictive biomarker for immunotherapy benefits in NRAS wildtype melanoma
2022 · Hongxia Li, Qin Zhang, et al. · Frontiers in Immunology · 12
NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer
2022 · Xiao-yang Gong, Hai-bin Chen, et al. · Frontiers in Immunology · 12
The clinical and genomic characteristics of MSI-h/dMMR lung cancer.
2022 · Jianwen Qin, Dongsheng Shi, et al. · Journal of Clinical Oncology · 10
A retrospective study of low-dose apatinib combined with S-1 in patients with advanced non-small cell lung cancer
2019 · Tong Zhou, Changling Wu, et al. · Journal of Thoracic Disease · 10
PDF
Age-dependent genomic characteristics and their impact on immunotherapy in lung adenocarcinoma
2022 · Peng Li, Shuyu Che, et al. · Journal of Cancer Research and Clinical Oncology · 9
Identification of IGF1R mutation as a novel predictor of efficacious immunotherapy in melanoma
2022 · Dongshen Ma, Qin Zhang, et al. · Journal of Translational Medicine · 7
PDF
Case Report: Neoadjuvant PD-1 Blockade Plus Concurrent Chemoradiotherapy in Unresectable Locally Advanced Gastric Cancer Patients
2021 · Jia Wei, Xiaofeng Lu, et al. · Frontiers in Oncology · 7
PDF
Prognostic patterns in invasion lymph nodes of lung adenocarcinoma reveal distinct tumor microenvironments
2024 · Shen Lao, Zisheng Chen, et al. · npj Precision Oncology · 6
Sintilimab Plus Fluorouracil, Leucovorin, Oxaliplatin and Docetaxel Regimen as Neoadjuvant Therapy for Resectable Gastric Cancer and Biomarker Exploration
2023 · Jiangpeng Wei, Xin Guo, et al. · Future Oncology · 5
Gastrointestinal signet ring cell malignancy: current advancement and future prospects
2023 · Weiping Hong, Qingjun Hu, et al. · Investigational New Drugs · 5
Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma
2023 · Shiqi Hu, Yaqin Liu, et al. · Investigational New Drugs · 5
Successful treatment of an adult patient with diffuse midline glioma employing olaparib combined with bevacizumab
2021 · Yong Wang, Jun Xu, et al. · Investigational New Drugs · 5
PDF
Immunotherapy Efficacy and Safety of Programmed Cell Death 1 (PD-1) versus Programmed Death Ligand-1 (PD-L1) Inhibitors in Pan-Cancer Patients: A Systematic Review and Meta-Analysis
2019 · Jianchun Duan, Longgang Cui, et al. · SSRN Electronic Journal · 5
Spectroscopic liquid biopsy: A novel promising method for early cancer screening
2025 · Chuang qi, Xiangwei Zhao · Journal of Translational Medicine · 4
PDF
Works count: 89
Citation count: 1,080
H-index: 12
I10-index: 15
Year
Topic
Type